• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期糖皮质激素治疗会改变人类受试者自发性脉冲式甲状旁腺激素的分泌动力学。

Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects.

作者信息

Bonadonna Stefania, Burattin Anna, Nuzzo Monica, Bugari Giovanna, Rosei Enrico Agabiti, Valle Domenico, Iori Nicoletta, Bilezikian John P, Veldhuis Johannes D, Giustina Andrea

机构信息

Department of Medical Sciences, University of Brescia, Brescia, Italy.

出版信息

Eur J Endocrinol. 2005 Feb;152(2):199-205. doi: 10.1530/eje.1.01841.

DOI:10.1530/eje.1.01841
PMID:15745926
Abstract

OBJECTIVE

Spontaneous parathyroid hormone (PTH) secretory dynamics include tonic and pulsatile components. It is not known how glucocorticoids might alter these secretory dynamics.

DESIGN

The aim of our study was to evaluate spontaneous fluctuations in serum PTH levels in six adult male patients (aged 31-64 years) receiving chronic (>6 months) therapy with glucocorticoids (daily dosage >7.5 mg of prednisone or dose equivalent of other corticosteroid) as compared with a control group of 10 age- and sex-matched normal subjects.

METHODS

Peripheral venous blood sampling was performed every 3 min for 6 h from 0900 to 1500 h. Plasma PTH release profiles were subjected to deconvolution analysis, a method that resolves measured hormone concentrations into secretion and clearance components, and to an approximate entropy (ApEn) estimate, that in turn provides an integrated measure of the serial regularity or orderliness of the release process.

RESULTS

In the glucocorticoid-treated group, the PTH tonic secretory rate was reduced (4.3+/-0.74 vs 8.8+/-1.4 pg/ml per min in controls, P = 0.017). There was, however, an increase in the fractional pulsatile PTH secretion (42+/-8.2 vs 18.3+/-3.9 pg/ml per min, P = 0.006) in glucocorticoid-treated vs normal subjects. Mean overall PTH concentration, as well as mean integrated area, was similar among normal and glucocorticoid-treated subjects.

CONCLUSIONS

These results demonstrate, for the first time, that chronic glucocorticoid treatment induces a redistribution of spontaneous PTH secretory dynamics by reducing the amount released in tonic fashion and increasing the amount released as pulses.

摘要

目的

甲状旁腺激素(PTH)的自发性分泌动力学包括持续性和脉冲性成分。目前尚不清楚糖皮质激素如何改变这些分泌动力学。

设计

我们研究的目的是评估6例接受糖皮质激素慢性(>6个月)治疗(每日剂量>7.5 mg泼尼松或其他皮质类固醇等效剂量)的成年男性患者(年龄31 - 64岁)血清PTH水平的自发性波动,并与10名年龄和性别匹配的正常受试者组成的对照组进行比较。

方法

在09:00至15:00期间,每3分钟采集一次外周静脉血样,共采集6小时。血浆PTH释放曲线进行去卷积分析,该方法将测得的激素浓度分解为分泌和清除成分,并进行近似熵(ApEn)估计,进而提供释放过程序列规律性或有序性的综合测量。

结果

在糖皮质激素治疗组中,PTH的持续性分泌率降低(4.3±0.74 vs对照组8.8±1.4 pg/ml每分钟,P = 0.017)。然而,与正常受试者相比,糖皮质激素治疗组中PTH脉冲性分泌分数增加(42±8.2 vs 18.3±3.9 pg/ml每分钟,P = 0.006)。正常受试者和糖皮质激素治疗组的平均总体PTH浓度以及平均积分面积相似。

结论

这些结果首次表明,慢性糖皮质激素治疗通过减少持续性释放量和增加脉冲释放量,诱导了自发性PTH分泌动力学的重新分布。

相似文献

1
Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects.长期糖皮质激素治疗会改变人类受试者自发性脉冲式甲状旁腺激素的分泌动力学。
Eur J Endocrinol. 2005 Feb;152(2):199-205. doi: 10.1530/eje.1.01841.
2
Episodic secretion of parathyroid hormone in postmenopausal women: assessment by deconvolution analysis and approximate entropy.绝经后女性甲状旁腺激素的间歇性分泌:通过去卷积分析和近似熵进行评估
J Bone Miner Res. 1997 Apr;12(4):616-23. doi: 10.1359/jbmr.1997.12.4.616.
3
Active acromegaly enhances spontaneous parathyroid hormone pulsatility.活动性肢端肥大症会增强甲状旁腺激素的自发性搏动性。
Metabolism. 2006 Jun;55(6):736-40. doi: 10.1016/j.metabol.2006.01.009.
4
Pulsatile secretion of parathyroid hormone in normal young subjects: assessment by deconvolution analysis.正常年轻受试者甲状旁腺激素的脉冲式分泌:通过反卷积分析进行评估。
J Clin Endocrinol Metab. 1993 Aug;77(2):399-403. doi: 10.1210/jcem.77.2.8345044.
5
PTH pulsatility but not calcium sensitivity is restored after total parathyroidectomy with heterotopic autotransplantation.甲状旁腺全切并异位自体移植后,甲状旁腺激素的脉冲性得以恢复,但钙敏感性未恢复。
J Am Soc Nephrol. 2003 Feb;14(2):407-14. doi: 10.1097/01.asn.0000043905.35268.86.
6
Altered diurnal regulation of blood ionized calcium and serum parathyroid hormone concentrations during parenteral nutrition.肠外营养期间血离子钙和血清甲状旁腺激素浓度的昼夜调节改变。
Am J Clin Nutr. 2000 Feb;71(2):560-8. doi: 10.1093/ajcn/71.2.560.
7
Control of pulsatile and tonic parathyroid hormone secretion by ionized calcium.离子钙对甲状旁腺激素脉冲式及持续性分泌的调控
J Clin Endocrinol Metab. 1996 Dec;81(12):4236-43. doi: 10.1210/jcem.81.12.8954021.
8
Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects.接受糖皮质激素治疗的受试者甲状旁腺激素水平未升高。
J Bone Miner Res. 1995 Nov;10(11):1713-8. doi: 10.1002/jbmr.5650101114.
9
Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats.正常及尿毒症大鼠甲状旁腺中甲状旁腺激素/甲状旁腺激素相关蛋白受体配体的自身调节作用
Kidney Int. 2003 Jul;64(1):63-70. doi: 10.1046/j.1523-1755.2003.00056.x.
10
Pulsatile-secretion of parathyroid hormone in patients with chronic renal failure.慢性肾衰竭患者甲状旁腺激素的脉冲式分泌
Clin Nephrol. 1993 Apr;39(4):224-8.

引用本文的文献

1
Pathophysiology and evaluation of bone health in adrenal diseases.肾上腺疾病中骨骼健康的病理生理学与评估
Endocrine. 2025 May 28. doi: 10.1007/s12020-025-04260-5.
2
Mild autonomous cortisol secretion: impact on bone health and quality of life. A review.轻度自主性皮质醇分泌:对骨骼健康和生活质量的影响。综述
Endocrine. 2025 Jun;88(3):693-700. doi: 10.1007/s12020-025-04203-0. Epub 2025 Feb 22.
3
Screening for endogenous hypercortisolism in patients with osteoporosis and fractures: why, when and how.骨质疏松症和骨折患者的内源性皮质醇增多症筛查:原因、时机及方法
J Endocrinol Invest. 2025 Apr;48(Suppl 1):23-31. doi: 10.1007/s40618-024-02450-y. Epub 2024 Oct 3.
4
Cushing's disease and bone.库欣病与骨骼
Pituitary. 2024 Dec;27(6):837-846. doi: 10.1007/s11102-024-01427-7. Epub 2024 Jul 15.
5
Bone Loss after Solid Organ Transplantation: A Review of Organ-Specific Considerations.实体器官移植后的骨质流失:器官特异性考虑因素的综述。
Endocrinol Metab (Seoul). 2024 Apr;39(2):267-282. doi: 10.3803/EnM.2024.1939. Epub 2024 Apr 25.
6
New insights into the vitamin D/PTH axis in endocrine-driven metabolic bone diseases.内分泌驱动代谢性骨病中维生素 D/PTH 轴的新见解。
Endocrine. 2024 Sep;85(3):1007-1019. doi: 10.1007/s12020-024-03784-6. Epub 2024 Apr 17.
7
Musculoskeletal complications of Cushing syndrome.库欣综合征的肌肉骨骼并发症
Reumatologia. 2023;61(4):271-282. doi: 10.5114/reum/169889. Epub 2023 Aug 31.
8
Effects of PTH glandular and external dosing patterns on bone cell activity using a two-state receptor model-Implications for bone disease progression and treatment.甲状旁腺激素腺体和外部分配模式对双状态受体模型中骨细胞活性的影响-对骨病进展和治疗的启示。
PLoS One. 2023 Mar 30;18(3):e0283544. doi: 10.1371/journal.pone.0283544. eCollection 2023.
9
High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study.大剂量静脉注射类固醇治疗似乎对年轻且新诊断的多发性硬化症患者的骨密度没有长期负面影响:一项初步研究。
Biomedicines. 2023 Feb 17;11(2):603. doi: 10.3390/biomedicines11020603.
10
Novel approaches to bone comorbidity in Cushing's disease: an update.库欣病骨合并症的新方法:更新。
Pituitary. 2022 Oct;25(5):754-759. doi: 10.1007/s11102-022-01252-w. Epub 2022 Jul 18.